The Asia Pacific Digital Patient Monitoring Devices Market is expected to witness market growth of 26.0% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Digital Patient Monitoring Devices Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $56.42 billion by 2031. The Japan market is expected to witness a CAGR of 25.2% during 2024-2031. Additionally, the India market would register a CAGR of 26.8% during 2024-2031.
The necessity to enhance healthcare accessibility in remote and underserved regions is also a contributing factor to the increasing demand for digital patient monitoring devices. In many regions, particularly rural and low-income areas, healthcare facilities are limited, and patients may face significant challenges in accessing timely care. Digital monitoring devices, in conjunction with telemedicine, provide a solution by allowing patients to receive continuous care without the need for frequent travel.
By facilitating remote monitoring, these devices enable healthcare providers to connect with patients who may not have convenient access to healthcare facilities, thereby enhancing health outcomes while decreasing disparities in healthcare access. This aspect of digital monitoring is particularly valuable for managing chronic conditions, as it allows patients to receive ongoing support and monitoring, even in scarce healthcare resources. Digital patient monitoring devices are indispensable in bridging the disparity between metropolitan and rural healthcare access as governments and healthcare organizations endeavor to render healthcare more equitable and accessible.
In India, where chronic diseases like diabetes and cardiovascular conditions are prevalent, digital monitoring devices are increasingly in demand. The National Library of Medicine reported that 77 million Indians had diabetes in 2019, projected to exceed 134 million by 2045. Additionally, India has high mental health disorder rates, impacting between 9.5 and 370 per 1,000 people, with an economic impact estimated at USD 1.03 trillion from 2012 to 2030. These monitoring devices provide vital support for mental and physical health, empowering individuals to manage their well-being where healthcare resources are limited. Thus, the Asia-Pacific region's unique healthcare needs and rapid technological development position it as a dynamic and growing market for digital patient monitoring devices.
The China market dominated the Asia Pacific Digital Patient Monitoring Devices Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $56.42 billion by 2031. The Japan market is expected to witness a CAGR of 25.2% during 2024-2031. Additionally, the India market would register a CAGR of 26.8% during 2024-2031.
The necessity to enhance healthcare accessibility in remote and underserved regions is also a contributing factor to the increasing demand for digital patient monitoring devices. In many regions, particularly rural and low-income areas, healthcare facilities are limited, and patients may face significant challenges in accessing timely care. Digital monitoring devices, in conjunction with telemedicine, provide a solution by allowing patients to receive continuous care without the need for frequent travel.
By facilitating remote monitoring, these devices enable healthcare providers to connect with patients who may not have convenient access to healthcare facilities, thereby enhancing health outcomes while decreasing disparities in healthcare access. This aspect of digital monitoring is particularly valuable for managing chronic conditions, as it allows patients to receive ongoing support and monitoring, even in scarce healthcare resources. Digital patient monitoring devices are indispensable in bridging the disparity between metropolitan and rural healthcare access as governments and healthcare organizations endeavor to render healthcare more equitable and accessible.
In India, where chronic diseases like diabetes and cardiovascular conditions are prevalent, digital monitoring devices are increasingly in demand. The National Library of Medicine reported that 77 million Indians had diabetes in 2019, projected to exceed 134 million by 2045. Additionally, India has high mental health disorder rates, impacting between 9.5 and 370 per 1,000 people, with an economic impact estimated at USD 1.03 trillion from 2012 to 2030. These monitoring devices provide vital support for mental and physical health, empowering individuals to manage their well-being where healthcare resources are limited. Thus, the Asia-Pacific region's unique healthcare needs and rapid technological development position it as a dynamic and growing market for digital patient monitoring devices.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- Hoffmann-La Roche AG
- Koninklijke Philips N.V
- Abbott Laboratories
- Boston Scientific Corporation
- OMRON Corporation
- Fitbit, Inc. (Google LLC)
- ResMed, Inc.
Market Report Segmentation
By Product
- Diagnostic Monitoring Devices
- Vital Sign Monitors
- Sleep Monitors
- Fetal Monitors
- Neuromonitors & Other Monitors
- Therapeutic Monitoring Devices
- Insulin Monitors
- Respiratory Monitors
- Other Monitors
By Type
- Wearable Devices
- Wireless Sensor Technology
- mHealth
- Telehealth
- Remote Patient Monitoring
- Hospital Inpatient
- Ambulatory Patient
- Smart Home Healthcare
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. Asia Pacific Digital Patient Monitoring Devices Market by Product
Chapter 6. Asia Pacific Digital Patient Monitoring Devices Market by Type
Chapter 7. Asia Pacific Digital Patient Monitoring Devices Market by Country
Chapter 8. Company Profiles
Companies Mentioned
Some of the leading companies profiled in this Asia-Pacific Digital Patient Monitoring Devices Market report include:- Siemens Healthineers AG (Siemens AG)
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- F. Hoffmann-La Roche AG
- Koninklijke Philips N.V
- Abbott Laboratories
- Boston Scientific Corporation
- OMRON Corporation
- Fitbit, Inc. (Google LLC)
- ResMed, Inc.
Methodology
LOADING...
